EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Chrysin Synergistically Reverses Chemoresistance in Ovarian Cancer by Inhibiting Epithelial-Mesenchymal Transition

Nan Zhang, Xiaoyuan Hao, Chunying Zhuang, Chenjing Zhu, Sicong Liu, Xiaoyuan Lu, Yuxian Xie, Ke’er Jiang, Mengyu Li, Jialin Zhu, Ting Luo, Xiaoxiao Liu, Buze Chen

Clinical and Experimental Obstetrics & Gynecology · 2026-10-19 · 53 (10)

DOI: 10.31083/ceog52655 ↗
AbstractBibliografische Angaben

Abstract

Background: Ovarian cancer (OC), a lethal gynecological malignancy, frequently develops resistance to cisplatin, which significantly contributes to chemotherapy failure. Chrysin, a natural flavonoid, has exhibited anti-tumor and chemosensitizing effects, but evidence specific to OC remains limited. Methods: Parental SKOV3 and CAOV3 cells were treated with chrysin alone to assess cell viability (cell counting kit-8 (CCK-8) and colony formation assays) and apoptosis (flow cytometry). The synergistic effects of chrysin combined with cisplatin were evaluated using CCK-8 assays and CompuSyn 1.0 software (ComboSyn, Inc., Paramus, NJ, USA). Subsequently, two cisplatin-resistant sublines (SKOV3/DDP and CAOV3/DDP) were generated by gradually increasing cisplatin exposure. Changes in epithelial-mesenchymal transition (EMT) protein levels between parental and resistant cells were compared using Western blotting, followed by repeated viability (CCK-8), colony formation, Transwell migration, and apoptosis (flow cytometry) assays in resistant lines. Transcriptome sequencing was performed to identify differentially expressed genes. Additionally, EMT-related proteins (E-cadherin, N-cadherin, vimentin, and Snail1) and components of the nuclear factor kappa B (NF-κB) pathway (p-P65, P105/P50, p-IKKα/β, and p-IκBα) were analyzed by Western blotting. A rescue experiment using the NF-κB activator phorbol 12-myristate 13-acetate (PMA) confirmed the involvement of the NF-κB pathway. Results: Chrysin inhibited proliferation, induced apoptosis, and synergistically enhanced the efficacy of cisplatin in both parental and cisplatin-resistant OC cells. Mechanistically, chrysin suppressed the NF-κB pathway, consequently reversing EMT associated with cisplatin resistance. Conclusions: Chrysin synergistically enhances cisplatin efficacy against OC, including cisplatin-resistant cells, by modulating the NF-κB/EMT pathway. These findings suggest that chrysin could serve as a promising strategy for overcoming cisplatin resistance and merit clinical investigation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →